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Aim To investigate the relationship between total serum 
cholesterol and levels of depression, aggression, and sui-
cidal ideations in war veterans with posttraumatic stress 
disorder (PTSD) without psychiatric comorbidity.
Methods A total of 203 male PTSD outpatients were as-
sessed for the presence of depression, aggression, and 
suicidality using the 17-item Hamilton Depression Rating 
Scale (HAM-D17), Corrigan Agitated Behavior Scale (CABS), 
and Scale for Suicide Ideation (SSI), respectively, followed 
by plasma lipid parameters determination (total cholester-
ol, high density lipoprotein [HDL]-cholesterol, low density 
lipoprotein [LDL]-cholesterol, and triglycerides). PTSD se-
verity was assessed using the Clinician-Administered PTSD 
Scale for DSM-IV, Current and Lifetime Diagnostic Version 
(CAPS-DX) and the Clinical Global Impressions of Severity 
Scale (CGI-S), before which Mini-International Neuropsy-
chiatric Interview (MINI) was administered to exclude psy-
chiatric comorbidity and premorbidity.
Results After adjustments for PTSD severity, age, body 
mass index, marital status, educational level, employment 
status, use of particular antidepressants, and other lipid 
parameters (LDL- and HDL- cholesterol and triglycerides), 
higher total cholesterol was significantly associated with 
lower odds for having higher suicidal ideation (SSI≥20) 
(odds ratio [OR] 0.09; 95% confidence interval [CI] 0.03-
0.23], clinically significant aggression (CABS≥22) (OR 0.28; 
95% CI 0.14-0.59), and at least moderate depressive symp-
toms (HAM-D17≥17) (OR 0.20; 95% CI 0.08-0.48). Association 
of total cholesterol and HAM-D17 scores was significantly 
moderated by the severity of PTSD symptoms (P < 0.001).
Conclusion Our results indicate that higher total serum 
cholesterol is associated with lower scores on HAM-D17, 
CABS, and SSI in patients with chronic PTSD.
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Posttraumatic stress disorder (PTSD) is one of the few men-
tal disorders with a clearly identifiable cause. It is an anxiety 
disorder caused by exposure to a traumatic event that pre-
sented a threat to the physical integrity of persons them-
selves or other people in their surroundings (1). Key neu-
rochemical PTSD features include altered catecholamines 
regulation, alterations in serotonergic system, and altera-
tions in systems of aminoacids, peptides, and opioid neu-
rotransmitters (2).
Associations between serum lipids and various psychiat-
ric disorders and some behavioral aspects (like aggressive 
behavior) and/or suicidality have been widely explored. 
Lower total cholesterol levels were predominantly found 
in patients with major depressive disorder (MDD) (3-9). 
Significantly higher high-density lipoprotein cholesterol 
(HDL-cholesterol) levels were found in depressive patients 
than in controls (7). Some studies found significantly low-
er HDL-cholesterol levels (10) and a lower HDL-cholester-
ol/total cholesterol ratio (5) in patients with MDD than in 
controls.
A negative correlation (11-13) between serum cholester-
ol level and aggressive behavior was also found, confirm-
ing the cholesterol-serotonergic hypothesis of aggression 
(14,15). Inadequate cholesterol intake could lead to de-
creased central serotonin activity, which is associated with 
an increased risk for impulsive-aggressive behavior (14-18). 
Depression (19-21) and aggression are well-known sui-
cidality risk factors (15,22).
The correlation between hypocholesterolemia, decreased 
central serotonin activity, increased depressive potential, 
and increased suicidality risk (23-27) was confirmed, im-
plicating that hypocholesterolemia might be indirectly, 
ie, through decreased central serotonin activity and in-
creased depression potential (20,25,28), associated with an 
increased suicidality risk (15,19-24,26,27). In patients with 
anxiety disorders other than PTSD, like panic disorder (PD), 
lower HDL-cholesterol and higher very low density lipo-
protein cholesterol (VLDL-cholesterol) levels were found to 
be associated with higher suicide ideations/risk (29). Signif-
icantly lower serum total cholesterol and LDL cholesterol 
levels were found in suicidal patients with PD than in con-
trol subjects (30).
Hypercholesterolemia was found to be associated with 
chronic, war-related PTSD (31-34). In a study from Bosnia 
and Herzegovina, not only hypercholesterolemia but also 
increased VLDL- and HDL-cholesterol levels were found in 
war veterans with PTSD in comparison with war veterans 
without psychiatric disorders (35). A Croatian study found 
no significant differences in the total serum cholesterol 
level, LDL-, and HDL-cholesterol between war veterans 
with PTSD, war veterans without PTSD, and healthy vol-
unteers (36).The aim of this study was to investigate the 
relationship between serum cholesterol and levels of de-
pression, aggression, and suicidal ideations in war veter-
ans with PTSD free of other psychiatric premorbidity and 
comorbidity.
PatientS and MethodS
Patients
This single-center, cross-sectional study included patients 
consecutively sampled from the pool of veterans involved 
in outpatient PTSD program at the Department for Biologi-
cal Psychiatry and Psychogeriatrics and the Department for 
Diagnostic and Intensive Treatment, University Psychiatric 
Hospital Vrapče, Zagreb, Croatia. The study was approved 
by the Ethics Committee of the Vrapče University Psychiat-
ric Hospital. The participants were not reimbursed for their 
participation in the study and received no benefit in their 
treatment in comparison with outpatients with PTSD treat-
ed in the same hospital but not included in the study. Par-
ticipants were consecutively recruited from January 2007 
till November 2012. Out of 427 examined potential study 
participants, 10 refused to participate and 214 were not eli-
gible for the study. Out of 203 included study participants, 
all 203 finished the study.
The study included adult men with chronic, war-related 
PTSD who met all of the following inclusion criteria: (i) 
signed an informed consent prior to any study procedure, 
(ii) male sex, (iii) age between 18 and 65 years, (iv) outpa-
tient status, and (v) confirmed PTSD according to both 
ICD-10 (37) and DSM-IV (1) criteria. The exclusion criteria 
were (i) premorbid or comorbid psychiatric disorders (in-
cluding alcohol and other dependence disorders, eating 
disorders, or any other psychiatric disorder or condition 
different from PTSD), (ii) significant somatic comorbidity 
(particularly those diseases and disorders, like metabolic, 
with significant influence on cholesterol and other serum 
lipids metabolism including malnutrition, malabsorption, 
chronic infections, consumptive disorders, hyper- and 
hypothyreosis, diabetes mellitus), (iii) BMI lover than 20 
kg/m2, and (iv) taking medicaments with significant in-
fluence on serum lipids metabolism (particularly hy-
polipemics).
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Psychiatric evaluation
All patients met the ICD-10 PTSD criteria, which is the offi-
cial classification used in Croatian psychiatric practice. PTSD 
severity was assessed by DSM-IV-based Clinician-Adminis-
tered PTSD Scale, Current and Lifetime Diagnostic Version 
(CAPS-DX) (38) and the Clinical Global Impressions of Se-
verity (CGI-S) scale (39), before which Mini-International 
Neuropsychiatric Interview (MINI) (40) was administered. 
MINI, a structured diagnostic interview, was used to con-
firm that each patient met DSM-IV PTSD criteria with the 
exclusion of psychiatric comorbidity and premorbidity.
After three consecutively administered scales (MINI, CAPS-
DX, and CGI-S), the following standardized psychometric 
instruments/questionnaires were used: Corrigan Agitated 
Behavior Scale (CABS) (41), 17-item Hamilton Depression 
Rating Scale (HAM-D17) (42), and the Scale for Suicide Ide-
ation (SSI) (43). CABS was used for assessment of the cur-
rent aggression level (aggressive behaviors), HAM-D17 for 
depression potential (subsyndromal depressive states), 
and SSI for suicidality potential (suicidal ideations). All six 
scales were applied by experienced psychiatrists, licensed 
for their administration. The scales were used in their origi-
nal formats and language, whereas the interview was con-
ducted in Croatian. HAM-D17 is one of the most frequently 
used clinician-administered depression assessment scales. 
It has 17 items; the score of 0-6 points is considered nor-
mal, while the score of 7-16 points indicates mild, 17-24 
points moderate, and ≥25 points severe depression. Scores 
≥17 points usually indicate clinically significant levels of 
depressive symptoms (42). Inter-rater reliability for HAM-
D17 is high, ranging from 0.80 to 0.98 for the total score rat-
ing. The test-retest reliability is also high, about 0.81. The 
validity of the HAM-D17 ranges from 0.65 to 0.90, with glob-
al measures of depression severity (44). In this study,HAM-
D17 reliability calculated as internal consistency (Cronbach’s 
α) was 0.66. The Guttman Split-Half Coefficient of reliability 
was 0.72 and the Spearman-Brown coefficient for unequal 
length scale half was 0.72.
CABS is an observational, clinician administered, as op-
posed to self-report, scale. Original validation study showed 
that trained therapists can use the scale with sufficient re-
liability and validity when based on therapists’ 30-minute 
observation periods (41). Each of the 14 items is rated on 
a 4-point rating scale and the total score is calculated by 
adding up the rating on each of 14 items. Scores of ≥22 
usually indicate a clinically significant result (41). In this 
study, Cronbach’s coefficient of internal CABS scale 
consistency was 0.96. The Guttman Split-Half Coefficient of 
reliability was 0.97 and the Spearman-Brown coefficient for 
unequal length scale half was 0.97.
The SSI is a 19-item clinician administered scale, widely 
used to quantify and assess suicidal intention. Each item 
consists of three alternative statements graded in inten-
sity from 0 to 2. The possible range of scores is 0-38. In-
ter-rater reliability for SSI is high with correlations ranging 
from 0.83 (43) to 0.98 (45).The SSI is one of the few suicide 
assessment instruments to have documented the predic-
tive validity for completed suicide. Psychiatric patients who 
entered the higher risk category were about seven times 
more likely to actually commit suicide than those who en-
tered the lower risk category (46). In this study, Cronbach’s 
coefficient of internal SSI scale consistency was 0.94. The 
Guttman Split-Half Coefficient of reliability was 0.88 and 
the Spearman-Brown coefficient for unequal length scale 
half was 0.94. All scale administrators in this study were ex-
perienced and licensed in applying the English version of 
the scales, all in accordance with psychiatric scientific prac-
tice in Croatia.
Medical assessment
General socio-demographic data: age, sex, marital and 
employment status, and educational level were collected 
by means of a clinical interview. Data on pharmacothera-
py influencing serum lipids metabolism and psychophar-
maceuticals taking, were collected from patients’ medical 
records. Data on significant somatic comorbidities were 
collected through physical examination and somatic ana-
mnesis. Body weight (in kilograms, kg) and body height (in 
meters, m) were measured and BMI was calculated accord-
ing to the following formula: BMI = weight in kg/ height in 
squared meters.
Biochemical analysis
Biochemical analyses were performed at the Laboratory of 
the Vrapče University Psychiatric Hospital. Lipid levels were 
determined using commercial tests: cholesterol (enzymat-
ic colorimetric method), HDL-cholesterol (homogeneous 
enzymatic colorimetric assay), LDL-cholesterol (homo-
geneous enzymatic colorimetric assay), and triglycerides 
(enzymatic colorimetric method with glycerol phosphate 
oxidase and 4-aminophenazone (GPO/PAP) (Roche Diag-
nostics, Mannheim, Germany). Concentrations were ex-
pressed in mmol/L. At two consecutive time points (sepa-
rated by less than 10 but more than two days), 10 mL of 
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blood was drawn from the cubital vein and levels of plas-
ma lipids were determined. Blood samples were drawn be-
tween 8:00 and 9:30 am, after 12 hours of overnight fasting. 
They were collected using a standardized process, all in ac-
cordance with the Helsinki Declaration (47). According to 
the mean total cholesterol value ([value from the first sam-
ple + value from the second sample]/2), each patient was 
classified into one of three groups: normal group (choles-
terol 3.1-5.1 mmol/L), borderline-high/high-normal group 
(cholesterol 5.2-6.2 mmol/L), and high cholesterol group 
(cholesterol >6.2 mmol/L), all in accordance with the cur-
rent international guidelines (48).
outcomes
Three outcomes were HAM-D17, CABS, and SSI scales re-
sults dichotomized as to indicate at least moderate depres-
sive symptoms (HAM-D17≥17), clinically significant aggres-
sion (CABS≥22), and higher – the upper quartile – suicidal 
ideation (SSI≥20).
Statistical analysis
The level of statistical significance was set at P < 0.05 and 
confidence intervals at 95%. In all instances, two-tailed 
tests were used. Principal component analysis with extrac-
tion criterion eigenvalues >1 and Vairmax rotation with 
Kaiser normalization was done in order to explore the pos-
sibility of reducing dimensionality of psychometric out-
comes. A univariate analysis of the relationship between 
lipid parameters, PTSD severity, patient’s living conditions, 
and therapy was performed by binary logistic regression. A 
multivariate analysis of relationship between total choles-
terol and three psychometric scales scores after adjustment 
for PTSD severity, age, BMI, marital status, educational level, 
employment status, the use of particular antidepressants, 
and other lipid parameters (LDL- and HDL-cholesterol and 
triglycerides) was done using hierarchical binary logistic 
regression. The moderating effect of PTSD severity on the 
association of total cholesterol and three psychometric 
scales scores was analyzed by Process (49). The CAPS value 
defining the region of statistically significant association 
of total cholesterol and three psychometric scales was as-
sessed by Johnson-Neyman technique as implemented in 
the Process. Data analysis was carried out by R (50).
ReSultS
Out of the 427 potential study participants, 203 met all in-
clusion criteria and had none of the exclusion criteria (10 
taBle 1. Baseline characteristics of 203 male patients with 
posttraumatic stress disorder (PtSd)*
Characteristic
age (years)† 47.0 (43.0-54.0)
PtSd symptoms severity score:
CAPS-DX total† 70.0 (65.0-76.0)
CGi-S
moderately ill, n (%) 111 (54.7)
markedly ill, n (%) 92 (45.3)
living conditions:
Marital status
married, n (%) 143 (70.4)
divorced, n (%) 41 (20.2)
single, n (%) 19 (9.4)
living alone
yes, n (%) 60 (29.6)
no, n (%) 143 (70.4)
educational level
elementary school, n (%) 70 (34.5)
high school, n (%) 122 (60.1)
>high school, n (%) 11 (5.4)
employment status
full-time, n (%) 37 (18.2)
part-time, n (%) 12 (5.9)
unemployed but able to work, n (%) 40 (19.7)
sick-leave and unemployed unable to work, n (%) 20 (9.9)
retired, n (%) 94 (46.3)
lipid parameters (mmol/l):†
total cholesterol 5.7 (5.0-6.0)
LDL-C 3.4 (2.9-3.8)
HDL-C 1.0 (1.0-1.4)
triglycerides 2.3 (1.5-2.9)
BMi† 26.1 (25.2-27.6)
therapy:
antidepressants
SSRI, n (%) 140 (69.0)
SNRI, n (%) 34 (16.7)
NaSSA, n (%) 29 (14.3)
anxiolytics
diazepam, n (%) 74 (36.5)
alprazolam, n (%) 58 (28.6)
clonazepam, n (%) 30 (14.8)
oxazepam, n (%) 25 (12.3)
lorazepam, n (%) 16 (7.9)
hypnotics
zolpidem, n (%) 159 (78.3)
nitrazepam, n (%) 44 (21.7)
Psychometric scales:†
SSI 13.0 (7.0-19.0)
CABS 19.0 (17.0-32.0)
HAM-D17 18.0 (16.0-22.0)
*abbreviations: CaPS – Clinician-administered PtSd Scale for dSM-iV, 
Current and lifetime diagnostic Version (38); a higher score reflects 
higher PtSd severity; CGi-S – Clinical Global impressions of Severity 
Scale (39); a higher score reflects higher PtSd severity; ldl-C – low 
density lipoprotein cholesterol; hdl-C – high density lipoprotein 
cholesterol; BMi – body mass index; SSRi – selective serotonin reuptake 
inhibitors; SnRi – serotonin norepinephrine reuptake inhibitors; naSSa 
– noradrenergic and specific serotonergic antidepressants; SSi – Scale 
for Suicide ideation (43); a higher score reflects higher suicidality poten-
tial; CaBS – Corrigan agitated Behavior Scale (41); a higher score reflects 
higher aggressive potential; haM-d17 – hamilton depression Rating 
Scale (42); a higher score reflects higher depressive potential.
†Median (interquartile range).
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refused to participate and 214 were not eligible for the 
study). Their median (interquartile range) age was 47.0 
years (43.0-54.0) and all of them were either moderate-
ly or markedly ill as measured by CGI-S (Table 1). All pa-
tients were treated with a combination of antidepressant, 
anxiolytic, and hypnotic treatment prescribed in standard 
medium dosages. By principal component analysis, 11 
principal components were extracted, explaining 75% of 
items variance. However, the first three components (cor-
responding to HAM-D17, CABS, and SSI scales) explained 
20%, 18%, and 9% of original items, respectively. All other 
components individually explained less than 4% of total 
variance. Varimax rotation with Kaiser normalization pro-
duced the structure matrix with very clear distinction be-
tween original HAMD, SSI, and CABS items. Therefore, we 
concluded that our three dependent variables were well 
discriminated, and that treating CABS, SSI, and HAM-D as 
separate outcomes was the most appropriate approach.
Univariate binary logistic regression revealed that high-
er total cholesterol and LDL-cholesterol were signifi-
cantly associated with lower odds for having higher sui-
cidal ideation (SSI≥20), clinically significant aggression 
(CABS≥22), and at least moderate depressive symptoms 
(HAM-D17≥17) (Table 2). Higher triglycerides were associ-
ated with lower odds for higher suicidal ideation and ag-
gression. After the adjustments for PTSD severity, age, BMI, 
marital status, educational level, employment status, use 
of particular antidepressants, and other lipid parameters 
(LDL and HDL cholesterol and triglycerides), higher total 
cholesterol was significantly associated with lower odds 
for having the higher suicidal ideation (SSI≥20), clinically 
significant aggression (CABS≥22), and at least moderate 
depressive symptoms (HAM-D17≥17) (Table 3). When the 
total cholesterol was removed from the equation adjusted 
for patients’ clinical characteristics, living conditions, and 
therapy, LDL-cholesterol was significantly negatively as-
sociated with lower odds for our three outcomes; HDL-
cholesterol and triglycerides were significantly associated 
with suicidal ideation but not with aggression or depres-
sive symptoms.
We found no significant moderating effect of PTSD se-
verity on the association of total cholesterol and high SSI 
scale score. Association of total cholesterol and HAM-D17 
score was significantly moderated by PTSD severity. At 
the 10th percentile of the CAPS scale result, association 
of total cholesterol and HAM-D17 score was not significant 
(odds ratio [OR] 0.46; 95% confidence interval [CI] 0.21-
1.01; P = 0.053). At the 90th percentile of the CAPS scale 
result, association of total cholesterol and HAM-D17 score 
was significant (OR 0.15; 95% CI 0.07-0.34; P < 0.001). The 
Johnson-Neyman technique revealed that association 
of total cholesterol and HAM-D17 score was significant at 
CAPS value of 59.1, which corresponds to -1.5 CAPS stan-
dard deviations. Although the overall moderating effect of 
PTSD severity on the association of total cholesterol and 
CABS was not significant (P = 0.395), the Johnson-Neyman 
technique revealed that association of total cholesterol 
and the CABS score was significant if the CAPS score was 
lower than 83.9, which corresponds to 1.5 CAPS standard 
deviation.
diSCuSSion
The present study found an independent association be-
tween higher serum total cholesterol and lower odds for 
having higher suicidal ideation (SSI≥20), clinically signifi-
cant aggression (CABS≥22), and at least moderate depres-
sive symptoms (HAM-D17≥17) in male war veterans with 
PTSD without other psychiatric comorbidities. The associ-
ation between total cholesterol and HAM-D17 scores and 
between total cholesterol and CABS scores was different in 
different PTSD severity groups. Consistently, previous stud-
ies reported higher prevalence of depressive symptoms 
in middle-aged men with lower cholesterol levels (≤4.5 
mmol/L) than in men with cholesterol levels between 6 
and 7 mmol/L (51). An American study failed to find a sig-
taBle 2. univariate association of lipid parameters with elevated SSi, CaBS, haM-d17 scales results (n = 203)*
Suicidal ideation (SSi≥20) aggression (CaBS≥22) depression (haM-d17≥17)
lipid parameters (mmol/l): oR (95% Ci) P oR (95% Ci) P oR (95% Ci) P
total cholesterol 0.10 (0.05-0.2) <0.001 0.33 (0.21-0.53) <0.001 0.26 (0.16-0.42) <0.001
LDL-C 0.27 (0.14-0.51) <0.001 0.41 (0.24-0.68) 0.001 0.45 (0.29-0.71) 0.001
HDL-C 0.90 (0.45-1.78) 0.755 1.28 (0.72-2.29) 0.399 0.89 (0.51-1.56) 0.684
triglycerides 0.63 (0.44-0.90) 0.010 0.71 (0.53-0.95) 0.023 0.83 (0.64-1.06) 0.139
*abbreviations: oR – odds ratio, univariate binary logistic regression; 95% Ci – 95% confidence interval; ldl-C – low density lipoprotein cholesterol; 
hdl-C – high density lipoprotein cholesterol; SSi – Scale for Suicide ideation (43); a higher score reflects higher suicidality potential; CaBS – Corrigan 
agitated Behavior Scale (41); a higher score reflects higher aggressive potential; haM-d17 – hamilton depression Rating Scale (42); a higher score 
reflects higher depressive potential.
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nificant difference in the severity of depressive symptoms 
between the group of middle-aged adults with low (<3.9 
mmol/L) and the group with total cholesterol ≥3.9 mmol/L 
(52). Various studies have found a negative association be-
tween total serum cholesterol and MDD, mostly associat-
ing lower levels of serum cholesterol with MDD (3-9,53,54). 
Higher serum cholesterol levels could be indirectly associ-
ated with lower levels of depression (depressive symptoms 
at a subsyndromal level) due to higher central serotonin 
activity than that expected in patients with lower serum 
cholesterol levels (25). Hypocholesterolemic status could 
be accompanied by more negative affective states at the 
clinical level (depressive symptoms more manifested, even 
in a full syndromal form – MDD) (20,25,28,51). However, in 
our PTSD population, neither low cholesterol levels nor 
MDD comorbidity were found.
In this study, a negative association between total choles-
terol and CABS score was found. Literature data linked low-
er total cholesterol levels to higher rates of aggressive and 
violent behavior (11-13,55,56). In our study, higher serum 
total cholesterol levels were accompanied by less mani-
fested agitation and aggressive behavioral patterns. De-
spite the lack of clinically significant manifestations of ag-
gressive behaviors, patients with normal serum cholesterol 
levels in our sample manifested more aggressive behav-
ioral patterns than those with borderline-high and high se-
rum cholesterol levels.
taBle 3. Multivariate association of lipid parameters after adjustment for possible confounders with elevated SSi, CaBS, haM-d17 
scales results (n = 203)*
Suicidal ideation (SSi≥20) aggression (CaBS≥22) depression (haM-d17≥17)
oR (95% Ci) P oR (95% Ci) P oR (95% Ci) P
lipid parameters* (mmol/l):
total cholesterol 0.09 (0.03-0.23) <0.001 0.28 (0.14-0.59) 0.001 0.20 (0.08-0.48) <0.001
LDL-C 1.27 (0.48-3.38) 0.629 1.05 (0.51-2.15) 0.894 1.47 (0.61-3.52) 0.391
HDL-C 0.97 (0.29-3.21) 0.956 1.73 (0.74-4.07) 0.209 1.15 (0.48-2.75) 0.751
triglycerides 0.90 (0.56-1.45) 0.669 0.90 (0.61-1.33) 0.604 0.99 (0.67-1.47) 0.970
Confounders:
Age (years) 1.00 (0.94-1.06) 0.886 0.98 (0.93-1.03) 0.484 1.01 (0.96-1.07) 0.618
BMI 0.97 (0.82-1.16) 0.756 1.02 (0.88-1.19) 0.768 1.04 (0.88-1.22) 0.665
CAPS 0.98 (0.93-1.03) 0.356 0.98 (0.94-1.02) 0.357 0.98 (0.94-1.02) 0.363
Marital status
married 1 1 1
divorced 1.04 (0.35-3.12) 0.945 1.47 (0.62-3.51) 0.381 2.75 (1.12-6.78) 0.028
single 0.96 (0.17-5.49) 0.960 1.17 (0.32-4.32) 0.811 0.69 (0.20-2.35) 0.548
educational level
elementary school 1 1 1
high school 0.91 (0.34-2.43) 0.852 0.81 (0.37-1.77) 0.598 1.21 (0.58-2.51) 0.619
>high school 4.45 (0.73-27.30) 0.104 0.58 (0.11-3.02) 0.515 3.80 (0.60-23.9) 0.156
employment status
full-time 1 1 1
part-time 0.69 (0.06-8.11) 0.767 4.02 (0.71-22.91) 0.117 0.63 (0.12-3.29) 0.580
unemployed but able to work 1.48 (0.34-6.43) 0.605 0.63 (0.16-2.47) 0.506 0.83 (0.27-2.50) 0.733
sick-leave and unemployed unable to work 2.30 (0.45-11.69) 0.315 3.18 (0.78-12.91) 0.106 3.99 (0.96-16.7) 0.058
retired 1.13 (0.31-4.06) 0.853 3.22 (1.11-9.32) 0.031 0.99 (0.39-2.50) 0.977
antidepressants
SSRI 1.24 (0.36-4.24) 0.737 0.28 (0.11-0.75) 0.011 0.24 (0.08-0.76) 0.016
SNRI 1.95 (0.43-8.85) 0.386 0.59 (0.18-1.91) 0.379 0.32 (0.09-1.18) 0.087
NaSSA 1 1 1
*abbreviations: oR – odds ratio, multivariate binary logistic regression; 95% Ci – 95% confidence interval; P – level of statistical significance; CaPS 
– Clinician-administered PtSd Scale for dSM-iV, Current and lifetime diagnostic Version (38); a higher score reflects higher PtSd severity; ldl-C – 
low density lipoprotein cholesterol; hdl-C – high density lipoprotein cholesterol; SSRi – selective serotonin reuptake inhibitors; SnRi – serotonin 
norepinephrine reuptake inhibitors; naSSa – noradrenergic and specific serotonergic antidepressants; SSi – Scale for Suicide ideation (43); a higher 
score reflects higher suicidality potential; CaBS – Corrigan agitated Behavior Scale (41); a higher score reflects higher aggressive potential; haM-d17 
– hamilton depression Rating Scale (42); a higher score reflects higher depressive potential.
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Similarly to our results, other studies (23,24,26,27) also re-
ported an association between low total cholesterol levels 
and suicidality, while one recent study found that only very 
low and very high cholesterol levels could be valid and re-
liable predictors of suicidal ideations incidence in elderly 
people (57).
In PTSD patients with high (>6.2 mmol/L) cholesterol levels 
and those with cholesterol levels within the upper range of 
borderline-high cholesterol category (cholesterol between 
5.5-6.2 mmol/L), suicidal ideations were less pronounced 
than in patients with cholesterol below this value (5.5 
mmol/L was the cut-off ) but with each subsequent lower-
ing of the serum cholesterol levels below the 5.5 mmol/L 
level, the SSI scores significantly increased. Our patients 
with normal serum total cholesterol levels had significant-
ly more pronounced suicidal tendencies than those with 
borderline-high and high cholesterol levels. According to 
the trend described above, an even stronger association 
between low serum total cholesterol levels and high SSI 
scores could be expected in rare cases of low serum cho-
lesterol. Serum cholesterol levels could represent cardio-
vascular risk factors, but it seems that they might have a 
protective effect against suicidal ideation in patients with 
PTSD. With a lowering of serum cholesterol values from 
high to normal levels, this protective effect weakens and 
suicidal tendencies increase, while with further lowering 
of serum cholesterol levels to hypocholesterolemic range, 
the increase becomes even more obvious.
Since some depressive symptoms may be attributed to 
PTSD clinical presentation, if the severity of PTSD symp-
toms reaches a critical level, their impact on the associa-
tion between total cholesterol and depressive symptoms 
could became clinically significant. Previous studies fo-
cused on depression (MDD) comorbidity in combat-relat-
ed PTSD suggest that PTSD may be a causal risk factor for 
subsequent depression (56). Depression comorbidity in 
PTSD has been associated with more severe and chronic 
symptomatology (58,59). Despite the fact that none of our 
patients had comorbid MDD, it seems that in patients with 
severe PTSD symptomatology (all of our patients were ei-
ther markedly or moderately ill), PTSD itself could present 
a causal risk factor for subsequent depression (in our pa-
tients at subsyndromal level, depressive symptoms were 
present but not MDD comorbidity), partially mediated via 
serum cholesterol.
A limitation of our study was the cross-sectional design 
– we had a single fasting lipid measurement so the 
reliability of our independent variables may be insufficient. 
Also, without a control group, we might not have taken 
into account some confounding effects.
In conclusion, our results indicate a negative association 
between total cholesterol and higher suicidal ideation, 
clinically significant aggression, and at least moderate de-
pressive symptoms. As a future research topic, we propose 
the analysis of a possible moderating effect of PTSD sever-
ity on the association of total cholesterol and the symp-
toms of depression. Monitoring of lipid level changes in 
PTSD patients could improve the therapeutic outcomes.
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